The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol.

The value of molecular monitoring for residual disease (MRD) in early morphological remitters among adults diagnosed with B cell ALL and treated according to the MRC UKALL12 protocol.

Bibliografiska uppgifter
Huvudupphovsmän: Foroni, L, Mitchell, W, Rai, L, Richards, S, Fielding, A, Goldstone, A
Materialtyp: Conference item
Publicerad: 2005

Liknande verk